This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

9 Stocks to Buy for a European Recovery

Stocks in this article: IMT HBC DEO BTI SNY REN RDS VOD NVS

4. HSBC Holdings (HBC)

Company profile: HSBC, with a market value of $102 billion, is among the largest banks in the world, with around 7,000 offices in 85 countries. Based in London, about 46% of its assets are in Europe.

Dividend Yield: 4.62%

Investor takeaway: Its shares are up 23% this year but have a three-year, average annual loss of 2%. Analysts give its shares four "buy" ratings, two "outperforms," and four "holds," according to a survey of analysts by Morningstar.

3. Imperial Tobacco Group (IMT)

Company profile: Imperial Tobacco, with a market value of $23 billion, is the world's fourth-biggest publicly traded international tobacco company with total annual volume of more than 300 billion cigarettes sold in more than 160 countries.

Dividend Yield: 4.35%

Investor takeaway: Its shares are up 0.6% this year and have a three-year, average annual return of 11%. Analysts give its shares five "buy" ratings, one "outperform," one "hold," and one "sell," according to a survey of analysts by Morningstar.

2. Royal Dutch Shell (RDSA)

Company profile: Royal Dutch Shell, with a market value of $228 billion, is one of the top energy companies in the world, with exploration, production and refining operations.

Dividend Yield: 4.38%

Investor takeaway: Its shares are up 1.3% this year and have a three-year, average annual return of 12%. Analysts give its shares five "buy" ratings, two "buy/holds," one "hold," and one "sell," according to a survey of analysts by Morningstar.

1. Novartis ( NVS)

Company profile: Novartis, with a market value of $135 billion, is a global health-care company based in Basel, Switzerland. It is a maker of pharmaceuticals, vaccines and diagnostics, generics, and consumer- and animal-health products..

Dividend Yield: 3.15%

Investor takeaway: Its shares are up 6.5% this year and have a three-year, average annual return of 11%. Analysts give its shares six "buy" ratings, one "buy/hold," and one "moderate sell," according to a survey of analysts by TheStreet.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs